The use of extracorporeal membrane oxygenation (ECMO) in severe acute respiratory
distress syndrome (ARDS) has increased considerably over the last several years …

Background No definitive conclusions have been drawn from the available data about the
utilization of extracorporeal membrane oxygenation (ECMO) to treat severe acute respiratory …

Background The efficacy of venovenous extracorporeal membrane oxygenation (ECMO) in
patients with severe acute respiratory distress syndrome (ARDS) remains controversial …

Before widespread diffusion of VV-ECMO for severe ARDS, new trials should test the
efficacy of early initiation of the technique with tight control of mechanical ventilation in the …

Extracorporeal membrane oxygenation (ECMO) was first introduced for patients with acute
respiratory distress syndrome (ARDS) in the 1970s. However, enthusiasm was tempered …

The purpose of this review is to examine the indications of extracorporeal membrane
oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS). This technique …

Objectives: Over the last decade, extracorporeal membrane oxygenation (ECMO) has
become a promising option for patients with severe acute respiratory distress syndrome …

Various approaches such as ventilator management involving lung-protective ventilation,
corticosteroids, prone positioning, and nitric oxide have failed to maintain sufficient lung …

After various observational studies demonstrated a benefit of extracorporeal membrane
oxygenation (ECMO) in the therapy of severe acute respiratory distress syndrome (ARDS) …

Despite advances in mechanical ventilation, severe acute respiratory distress syndrome
(ARDS) is associated with high morbidity and mortality rates ranging from 26% to 58 …